Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL
· Real-Time Price · USD
0.77
0.01 (1.32%)
At close: May 01, 2025, 3:59 PM
0.77
-0.27%
After-hours: May 01, 2025, 05:24 PM EDT
1.32% (1D)
| Bid | 0.61 |
| Market Cap | 21.51M |
| Revenue (ttm) | 11.71M |
| Net Income (ttm) | -9.57M |
| EPS (ttm) | -0.34 |
| PE Ratio (ttm) | -2.27 |
| Forward PE | -2.71 |
| Analyst | Hold |
| Ask | 0.77 |
| Volume | 246,476 |
| Avg. Volume (20D) | 158,911 |
| Open | 0.70 |
| Previous Close | 0.76 |
| Day's Range | 0.70 - 0.84 |
| 52-Week Range | 0.33 - 1.65 |
| Beta | 1.24 |
About SLGL
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream ...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 1, 2018
Employees 36
Stock Exchange NASDAQ
Ticker Symbol SLGL
Website https://www.sol-gel.com
Analyst Forecast
According to 2 analyst ratings, the average rating for SLGL stock is "Hold." The 12-month stock price forecast is $5, which is an increase of 547.67% from the latest price.
Stock ForecastsNext Earnings Release
Sol-Gel Technologies Ltd. is scheduled to release its earnings on May 13, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
+3%
Sol-Gel Technologies shares are trading higher aft...
Unlock content with
Pro Subscription
